Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.
Allergy
; 70(10): 1319-28, 2015 Oct.
Article
in En
| MEDLINE
| ID: mdl-26016741
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Complement C1 Inhibitor Protein
/
Angioedemas, Hereditary
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Allergy
Year:
2015
Document type:
Article
Affiliation country:
United States
Country of publication:
Denmark